Brandon Young
![](/storage/faces/Brandon Young.png)
Brandon Young has 20 years of experience utilizing technology to improve testing and detection of genetic variation in human diseases. He was one of the early laboratory pioneers in microarray and gene sequencing projects in startup companies and large academic institutions. He has extensive experience in research, set-up, operations, configuration and P&L of running genomics labs. He has provided data and analysis for multiple national and international clinical trials.
Brandon has helped design, build and run labs for a number of prestigious centers throughout the US, including Scripps Florida, Human Longevity Institute (HLI), and Avera McKennan. His current work with the Darwin Foundation is providing next generation sequencing services to support groundbreaking clinical studies for the WIN consortium, focusing on personalized precision oncology testing and treatment protocols. This early stage work is generating over 50% improvements in clinical outcomes for participating cancer patients.
Brandon has helped design, build and run labs for a number of prestigious centers throughout the US, including Scripps Florida, Human Longevity Institute (HLI), and Avera McKennan. His current work with the Darwin Foundation is providing next generation sequencing services to support groundbreaking clinical studies for the WIN consortium, focusing on personalized precision oncology testing and treatment protocols. This early stage work is generating over 50% improvements in clinical outcomes for participating cancer patients.